Hidden calcium risk in Steroid-Treated kids
NCT ID NCT07194213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how often children with steroid-dependent nephrotic syndrome have high calcium levels in their urine (hypercalciuria). Researchers will check 50 children aged 2 to 16 who are on steroid treatment. The goal is simply to find out how common this condition is, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2024
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children diagnosed with steroid-dependent nephrotic syndrome who are being followed up at the pediatric nephrology clinic.
- Ages
-
2 to 16 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \- Age between 2 and 16 years. * Diagnosis of steroid-dependent nephrotic syndrome (according to standard clinical criteria). * Currently in remission or relapse while on steroid therapy. Exclusion Criteria: * \- Children with congenital or secondary nephrotic syndrome. * Presence of other chronic kidney diseases. * Use of medications that affect calcium metabolism (other than steroids). * Children with systemic diseases affecting bone or mineral metabolism.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hupercalciurea are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag university hospital
Sohag, 82524, Egypt
-
Sohag university hospital
Sohag, Egypt